Automated technology streamlines astatine-211 production for cancer therapy

Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy.

Reused Pacemakers Good as New in Early Safety Data

CHICAGO — Secondhand permanent pacemaker use in poorer countries, following thorough cleaning and repackaging, has not resulted in patient harm so far, according to the

November 19, 2024

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 04.09.2024 / 10:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

September 5, 2024

Huntington’s Disease Chorea Gets New Treatment

The FDA expanded the label for valbenazine (Ingrezza) capsules to include chorea associated with Huntington’s disease, Neurocrine Biosciences announced Friday. Valbenazine is an inhibitor of

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.